The Conference on Retroviruses and Opportunistic Infections (CROI) takes place virtually from February 12-16. The entire program will be accessible live and via on-demand playback to all registered attendees through the conference platform. HPTN researchers will present 10 abstracts (six oral; four posters) covering HPTN 069, HPTN 071, HPTN 082, HPTN 083, HPTN 084, HVTN 130/HPTN 089, HPTN Modelling Centre, and CoVPN 5002.
HPTN at CROI 2022
46 - SARS-CoV-2 Prevalence in Children and Adults in 15 US Communities (CoVPN 5002 / The Compass Study) – Jessica E. Justman
836 - Estimating Benefits From Using On-Demand Oral PrEP by MSM in US (HPTN Modelling Centre) – Sarah Stansfield
97 - Symptom Durating in COVID-19 Convalescent Patients: Regional & Clinical Associations (HVTN 405/HPTN 1901) – Jorge A. Gallardo-Cartagena
81 - Phase 1 Study of Combination Anti-HIV Neutralizing Antibodies in HIV Negative Adults (HVTN 130/HPTN 089) – Magdalena E. Sobieszczyk
86 - Counterfactual Estimation of CAB-LA Efficacy Against Placebo Using External Trial Data (HPTN 084) – Deborah Donnell
96 - Updated Efficacy, Safety, and Case Studies in HPTN 083: CAB-LA vs. TDF/FTC for PrEP (HPTN 083) – Raphael J. Landovitz
87 - Different HIV Protection for Traditional and Medical Circumcision (HPTN 071 / POPART) – Kidist B. Zewdie
95 - CAB-LA PrEP: Early Detection of HIV Infection may Reduce INSTI Resistance Risk (HPTN 083) – Susan Eshleman
842 - A Tool to Assess HIV Prevention Readiness of Adolescent Girls and Young Women (HPTN 082) – Geetha Beauchamp
859 - Expectations of Preventive Benefits and HIV-Related Risk Behaviors (HPTN 069) – Jeremy Sugarman
700 - Evaluation of CAB-LA Safety and PK in Pregnant Women in the Blinded Phase of HPTN 084 (HPTN 084) – Sinead Delany-Moretlwe